MarginsXMarginsX
Home › Markets › Health Care › MIRA

MIRA Pharmaceuticals Inc. (MIRA)

MIRA trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.6310
-4.38% on the day
Market cap
$26.5M
Nano cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerMIRA on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2023
SEC CIK0001904286
SEC industry codePharmaceutical Preparations
Incorporated inFL

Financials

Not reported in SEC XBRL data.

Warning signs

Cash runway
9.3 months
$3.6M cash at June 30, 2026
Share count, 1 year
+120.4%
2025-08-13 to 2026-08-10 · +184.3% over 3 years
Going-concern doubt
Yes
10-Q filed August 12, 2026
Insider net buying, 12 months
-$1.3M
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These factors raise substantial doubt about the Company's ability to continue as a going concern for a period of twelve months from the issuance date of this Quarterly Report."
10-Q 2026-08-12
Cash and burn$3.6M cash; operating cash flow -$1.2M a quarter.Report 2026-06-30
Shares outstanding42,022,087 (2026-08-10); 19,069,315 a year earlier; 14,780,885 three years earlier.Cover page 2026-08-10
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 1 424B5 takedowns, 1 at the marketLatest 2025-12-05
Exchange deficiency notices, 12 months1 (8-K item 3.01)8-K 2026-07-31
AuditorSalberg & Company, P.A., Boca Raton, Florida, United States; changed auditors 1 time in 24 months8-K 4.01 2024-12-20
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $1.3M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
Not filed-$1.2M-$1.2M$3.6MNo debt tagsNeeds four quarters10-Q 2026-08-12
Q1 2026
2026-03-31
Not filed-$1.2M-$1.2M$4.8MNo debt tagsNeeds four quarters10-Q 2026-08-12
Q4 2025
2025-12-31
Not filed-$6.0M-$1.1M$6.3MNo debt tagsNeeds four quarters10-K 2026-03-31
Q3 2025
2025-09-30
Not filed-$1.1M-$1.1M$2.6MNo debt tagsNeeds four quarters10-Q 2025-11-13
Q2 2025
2025-06-30
Not filed-$1.5M-$800K$730KNo debt tagsNeeds four quarters10-Q 2026-08-12
Q1 2025
2025-03-31
Not filed-$1.8M-$1.6M$1.2MNo debt tagsNeeds four quarters10-Q 2026-08-12
Q4 2024
2024-12-31
Not filed-$2.4M-$1.8M$2.8MNo debt tagsNeeds four quarters10-K 2026-03-31
Q3 2024
2024-09-30
Not filed-$2.0M-$1.8M$4.1MNo debt tagsNeeds four quarters10-Q 2025-11-13

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52025-12-05
Latest annual report10-K2026-03-31
Latest quarterly / interim10-Q2026-08-12
Latest current report8-K2026-10-28
Latest proxyDEF 14A2026-07-28

Source: SEC EDGAR submissions feed, 198 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+15.6%
1 month-0.9%
3 months-12.0%
Year to date-56.3%
1 year-50.7%
From 52-week high-59.5%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
RMTIRockwell Medical Inc.$6.76-4.38%$26.9M
ACETAdicet Bio Inc.$2.75-1.08%$25.7M
LITSLite Strategy Inc.$0.8565+1.16%$25.6M
EDSAEdesa Biotech Inc. Common Shares$1.89-2.58%$25.5M
AARDAardvark Therapeutics Inc.$1.26-5.26%$27.6M
ABVCABVC BioPharma Inc.$0.9400+3.30%$25.4M
CRVOCervoMed Inc.$1.67-1.18%$25.3M
IMMPImmutep Limited$3.40-2.30%$25.1M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier